India's First Homegrown FDA Drug | Is Airtel's Fast Lane Fair? | Godrej Enters Wealth

from Top of the Morning · host Mint - HT Smartcast

Good Morning, I'm Nelson John. Today on Top of the Morning: Godrej launches its wealth arm with a ₹1 lakh crore target. Wockhardt wins FDA approval for India's first fully homegrown new drug. The weak rupee is squeezing AI startups, and founders are getting creative. The regulator looks set to clear Airtel's priority 5G plan. And the Supreme Court closes the casino industry's tax loophole. Five stories, ten minutes, no fluff. Listen now. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Jun 2, 2026

Embed this episode

Attribution link and audio player

Ready to play

India's First Homegrown FDA Drug | Is Airtel's Fast Lane Fair? | Godrej Enters Wealth

0:00 15:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Top of the Morning?

This episode is 15 minutes long.

When was this Top of the Morning episode published?

This episode was published on June 2, 2026.

Can I download this Top of the Morning episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!